Recently released market study: Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

2012-04-25 16:32:50 - Fast Market Research recommends "Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019" from GlobalData, now available

Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, "Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Anal Cancer Therapeutics market. The report identifies the key trends shaping and driving the global Anal

Cancer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Anal Cancer Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.


Full Report Details at
- www.fastmr.com/prod/381286_anal_cancer_therapeutics_pipeline_ass ..


Scope

The report provides information on the key drivers and challenges of the Anal Cancer Therapeutics market. Its scope includes -

* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Anal Cancer Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Anal Cancer Therapeutics market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Anal Cancer Therapeutics market.
* Analysis of key recent licensing and partnership agreements in Anal Cancer Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Anal Cancer Therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Anal Cancer Therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Anal Cancer Therapeutics market landscape? - Identify, understand and capitalize.

Companies Mentioned in this Report: YM BioSciences Inc. (YM BioSciences), PDS Biotechnology Corporation (PDS)

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Anal Cancer Therapeutics - Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology and Pathophysiology
2.4 Risk Factors for Anal Cancer
2.5 Symptoms
2.6 Diagnosis
2.6.1 Physical Exam and History
2.6.2 Endoscopy
2.6.3 Biopsy
2.6.4 Ultrasound
2.6.5 Digital Rectal Examination (DRE)
2.6.6 CT (Computerized Tomography) Scan
2.6.7 Human Papillomavirus Test
2.6.8 Other Recent Methods to Detect HPV Infections
2.7 Staging of Anal Cancer
2.8 Treatment for Patients with Anal Cancer
2.8.1 Surgery
2.8.2 Radiation Therapy
2.8.3 Chemotherapy
2.8.4 Limitations of Current HPV Vaccines
2.9 Treatment by Stage of the Disease
2.10 GlobalData Pipeline Report Guidance
3 Anal Cancer Therapeutics - Market Characterization
3.1 Anal Cancer Therapeutics Market Size (2006-2011) - Global
3.2 Anal Cancer Therapeutics Market Forecast (2011-2019) - Global
3.3 Anal Cancer Therapeutics Market Size (2006-2011) - The US
3.4 Anal Cancer Therapeutics Market Forecast (2011-2019) - The US
3.5 Anal Cancer Therapeutics Market Size (2006-2011) - The UK
3.6 Anal Cancer Therapeutics Market Forecast (2011-2019) - The UK
3.7 Anal Cancer Therapeutics Market Size (2006-2011) - France
3.8 Anal Cancer Therapeutics Market Forecast (2011-2019) - France
3.9 Anal Cancer Therapeutics Market Size (2006-2011) - Germany
3.10 Anal Cancer Therapeutics Market Forecast (2011-2019) - Germany
3.11 Anal Cancer Therapeutics Market Size (2006-2011) - Italy
3.12 Anal Cancer Therapeutics Market Forecast (2011-2019) - Italy
3.13 Anal Cancer Therapeutics Market Size (2006-2011) - Spain
3.14 Anal Cancer Therapeutics Market Forecast (2011-2019) - Spain
3.15 Anal Cancer Therapeutics Market Size (2006-2011) - Japan
3.16 Anal Cancer Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Anal Cancer Therapeutics Market
3.17.1 Drivers for the Anal Cancer Therapeutics Market
3.17.2 Barriers for the Anal Cancer Therapeutics Market
3.18 Opportunity and Unmet Need
3.18.1 Opportunity and Unmet Need for the Anal Cancer Therapeutics Market
3.19 Key Takeaway
4 Anal Cancer Therapeutics Market - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=381286&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.